Acadia Pharmaceuticals Inc
2013 Q4 - 2025 Q4 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 14,224 | 0.0% | 532,533 | 12/31/2025 |
| 2025 Q2 | 8/14/2025 | 16,987 | 0.0% | 787,524 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 13,356 | 0.0% | 804,119 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 11,524 | 0.0% | 628,016 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 6,356 | 0.0% | 413,269 | 9/30/2024 |
| 2024 Q2 | 8/14/2024 | 7,509 | 0.0% | 462,078 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 21,663 | 0.0% | 1,171,624 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 26,489 | 0.0% | 846,028 | 12/31/2023 |
| 2023 Q3 | 11/15/2023 | 21,890 | 0.0% | 1,050,394 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 21,867 | 0.0% | 913,025 | 6/30/2023 |
| 2023 Q1 | 5/15/2023 | 16,412 | 0.0% | 872,050 | 3/31/2023 |
| 2022 Q4 | 8/11/2023 | 14,797 | 0.0% | 929,277 | 12/31/2022 |
| 2022 Q3 | 8/11/2023 | 14,971 | 0.0% | 916,398 | 9/30/2022 |
| 2022 Q2 | 8/11/2023 | 12,763 | 0.0% | 905,013 | 6/30/2022 |
| 2022 Q1 | 8/11/2023 | 21,207 | 0.0% | 875,122 | 3/31/2022 |
| 2021 Q4 | 2/16/2022 | 18,530 | 0.0% | 793,900 | 12/31/2021 |
| 2021 Q3 | 11/12/2021 | 16,947 | 0.0% | 1,020,260 | 9/30/2021 |
| 2021 Q2 | 8/12/2021 | 24,141 | 0.0% | 989,813 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 15,733 | 0.0% | 609,810 | 3/31/2021 |
| 2020 Q4 | 2/12/2021 | 15,125 | 0.0% | 282,915 | 12/31/2020 |
| 2020 Q1 | 5/15/2020 | 3,042 | 0.0% | 72,006 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 2,735 | 0.0% | 63,932 | 12/31/2019 |
| 2014 Q1 | 5/15/2014 | 1,300 | 0.0% | 53,440 | 3/31/2014 |
| 2013 Q4 | 5/1/2014 | 1,342 | 0.0% | 53,687 | 12/31/2013 |